Abstract
Immunotherapy based on monocyte derived dendritic cells constitutes a promising strategy for the treatment of individuals infected with HIV. Protocols for obtaining conventional DCs use mediators of cell differentiation like IL4 and GMCSF that differentiate monocytes to immature DCs with myeloid cell characteristics. The stimulation with pro-inflammatory cytokines (TNF-alpha, IL-1beta and…